Roman Rouzier

Q: What Schools Are Affiliated With Roman Rouzier

Roman Rouzier is affiliated with the following schools: Paris Sciences et Lettres University, Université Paris Cité

Roman Rouzier's AcademicInfluence.com Rankings

Roman Rouzier

Biology

#11581

World Rank

#14985

Historical Rank

Biotechnology

#193

World Rank

#195

Historical Rank

biology Degrees

Download Badge

Biology

Roman Rouzier's Degrees

PhD Biomedical Sciences Université Paris Cité
Masters Biotechnology Université Paris Cité

Why Is Roman Rouzier Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roman Rouzier's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy (2005) (1851)
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. (2006) (714)
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. (2004) (583)
Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). (2011) (447)
Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer (2012) (412)
Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis. (2009) (385)
Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. (2005) (383)
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. (2005) (369)
Breast cancer with synchronous metastases: trends in survival during a 14-year period. (2004) (361)
Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. (2002) (292)
Quality of life after laparoscopic colorectal resection for endometriosis. (2006) (270)
Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma (2005) (262)
Hypertrophy of labia minora: experience with 163 reductions. (2000) (258)
Randomized Trial of Laparoscopically Assisted Versus Open Colorectal Resection for Endometriosis: Morbidity, Symptoms, Quality of Life, and Fertility (2010) (239)
Breast cancer in pregnancy: recommendations of an international consensus meeting. (2010) (236)
Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. (2009) (236)
Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. (2003) (235)
Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. (2007) (211)
Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. (2011) (195)
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. (2005) (191)
Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: a French collaborative study. (2008) (172)
Adnexal masses: development and preliminary validation of an MR imaging scoring system. (2013) (163)
Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study. (2003) (158)
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. (2004) (156)
Dynamic contrast‐enhanced magnetic resonance imaging: A useful tool for characterizing ovarian epithelial tumors (2008) (155)
Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. (2003) (150)
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response (2004) (149)
How to differentiate benign from malignant myometrial tumours using MR imaging (2013) (145)
Laparoscopic segmental colorectal resection for endometriosis: limits and complications (2007) (143)
Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. (2001) (140)
Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis. (2014) (134)
Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. (2010) (130)
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study (2018) (128)
Anaphylactic response to blue dye during sentinel lymph node biopsy. (2011) (124)
External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. (2008) (119)
Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals. (2007) (117)
Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. (2015) (115)
Outcome of laparoscopic colorectal resection for endometriosis (2007) (107)
Taxanes for breast cancer during pregnancy: a systematic review. (2010) (107)
The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma (2011) (104)
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. (2005) (102)
Urinary complications after surgery for posterior deep infiltrating endometriosis are related to the extent of dissection and to uterosacral ligaments resection. (2008) (102)
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area (2020) (100)
Local Relapse in Patients Treated for Squamous Cell Vulvar Carcinoma: Incidence and Prognostic Value (2002) (98)
Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study (2012) (96)
Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses (2013) (91)
The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. (2005) (90)
Determinants of pregnancy rate in the donor oocyte model: a multivariate analysis of 450 frozen-thawed embryo transfers. (2009) (89)
Use of the SF-36 questionnaire to predict quality-of-life improvement after laparoscopic colorectal resection for endometriosis. (2008) (88)
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. (2010) (88)
Results of conservative management of epithelial malignant and borderline ovarian tumours. (2003) (88)
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer (2017) (85)
Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. (2002) (81)
Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer (2010) (81)
Breast cancer stroma frequently recruits fetal derived cells during pregnancy (2008) (80)
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials (2015) (79)
Fertility after colorectal resection for endometriosis: results of a prospective study comparing laparoscopy with open surgery. (2011) (79)
Microtubule Associated Protein (MAP)-Tau: A Novel Mediator of Paclitaxel Sensitivity In Vitro and In Vivo (2005) (78)
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial. (2009) (74)
Breast‐conserving surgery after neoadjuvant anthracycline‐based chemotherapy for large breast tumors (2004) (72)
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial. (2017) (72)
Laparoscopic total pelvic exenteration for cervical cancer relapse. (2003) (72)
Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer (2017) (72)
Immediate Reconstruction After Neoadjuvant Chemotherapy: Effect on Adjuvant Treatment Starting and Survival (2005) (68)
Use of the Sentinel Node Procedure to Stage Endometrial Cancer (2008) (67)
Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors. (2008) (66)
Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas. (2001) (66)
Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas (2013) (66)
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer. (2017) (64)
Risk of breast cancer associated with papilloma. (2008) (63)
Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? (2012) (63)
Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer (2006) (60)
The role of lymph node resection in ovarian cancer: analysis of the surveillance, epidemiology, and end results (SEER) database (2010) (60)
A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. (2012) (60)
Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study (2009) (60)
Germline RAD51C mutations in ovarian cancer susceptibility (2013) (58)
Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers (2011) (58)
Tumoral heterogeneity of breast cancer. (2016) (57)
Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor-positive, human epidermal growth factor receptor 2-negative early-stage breast cancer. (2016) (57)
Sentinel lymph node biopsy in gynaecological cancers: the importance of micrometastases in cervical cancer. (2008) (55)
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast (2018) (54)
Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications. (2010) (54)
Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization. (2011) (54)
Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2. (2008) (52)
CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy. (2014) (52)
A single-institution study of 117 pregnancy-associated breast cancers (PABC): Presentation, imaging, clinicopathological data and outcome. (2014) (52)
Comparative Analysis of Durable Responses on Immune Checkpoint Inhibitors Versus Other Systemic Therapies: A Pooled Analysis of Phase III Trials. (2018) (51)
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma (2018) (50)
Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma. (2015) (49)
Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. (2003) (48)
Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey (2015) (48)
Increased fetal cell microchimerism in high grade breast carcinomas occurring during pregnancy (2009) (47)
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9–14 years: Results to month 12 from a randomized trial (2015) (47)
HLA‐G1 and HLA‐G5 active dimers are present in malignant cells and effusions: The influence of the tumor microenvironment (2012) (46)
Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 cases. (2011) (45)
Impact of lymphovascular space invasion on a nomogram for predicting lymph node metastasis in endometrial cancer. (2013) (45)
Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study. (2015) (45)
Predictive factors for complete excision and underestimation of one-pass en bloc excision of non-palpable breast lesions with the Intact(®) breast lesion excision system. (2012) (45)
Expression of MMP-2, −7, −9, MT1-MMP and TIMP-1 and −2 has no prognostic relevance in patients with advanced epithelial ovarian cancer (2012) (44)
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. (2005) (44)
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort (2015) (43)
Specimen radiography as predictor of resection margin status in non-palpable breast lesions. (2006) (43)
Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population (2015) (42)
Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy? (2010) (42)
The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes (2008) (42)
The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma (2004) (42)
Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors (2014) (40)
Expression of sigma 1 receptor in human breast cancer (2004) (40)
Psychometric properties of the French Female Sexual Function Index (FSFI) (2014) (40)
Comparison of Diagnostic Accuracy of Frozen Section with Imprint Cytology for Intraoperative Examination of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Results of Senti-Endo Study (2012) (39)
Preoperative evaluation of posterior deep-infiltrating endometriosis demonstrates a relationship with urinary dysfunction and parametrial involvement. (2011) (39)
Staging for endometrial cancer: The controversy around lymphadenectomy - Can this be resolved? (2015) (39)
Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery. (2012) (39)
Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer. (2009) (38)
Ultrastaging of lymph node in uterine cancers (2010) (38)
Polarity gene alterations in pure invasive micropapillary carcinomas of the breast (2014) (38)
Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes. (2009) (38)
Chemotherapy for breast cancer during pregnancy: is epirubicin safe? (2008) (37)
Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches. (2010) (37)
Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines (2004) (36)
Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy (2009) (35)
Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program. (2010) (35)
Systematic cavity shaving: modifications of breast cancer management and long-term local recurrence, a multicentre study. (2013) (34)
A double blind randomized trial of wound infiltration with ropivacaine after breast cancer surgery with axillary nodes dissection (2011) (34)
A suggested modification to FIGO stage I endometrial cancer. (2014) (34)
The Usefulness of a Preoperative Compact Imager, a Hand-Held γ-Camera for Breast Cancer Sentinel Node Biopsy: Final Results of a Prospective Double-Blind, Clinical Study (2011) (34)
The natural history of breast carcinoma in patients with ≥ 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy (2005) (34)
Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer (2009) (33)
Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay (2016) (33)
Contribution of the sentinel node procedure to tailoring the radicality of hysterectomy for cervical cancer. (2007) (33)
The role of neoadjuvant chemotherapy in ovarian cancer (2018) (33)
Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy. (2018) (32)
Ovarian cancer in the elderly: impact of surgery on morbidity and survival. (2011) (32)
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer (2012) (32)
Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study (2018) (31)
Survival impact and predictive factors of axillary recurrence after sentinel biopsy. (2016) (31)
Sexual and functional results after creation of a neovagina in women with Mayer-Rokitansky-Küster-Hauser syndrome: a comparison of nonsurgical and surgical procedures. (2013) (31)
ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas (2016) (30)
Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma (2015) (30)
Abdominal Surgery in Chronic Hemodialysis Patients (1999) (30)
Development and internal validation of a nomogram to predict macrosomia (2007) (30)
Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site (2020) (30)
The survival impact of systematic lymphadenectomy in endometrial cancer with the use of propensity score matching analysis. (2012) (29)
Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy (2019) (29)
Trends in Treatment and Survival of Late-Stage Squamous Cell Vulvar Carcinomas: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database (2012) (29)
Analyse coût-efficacité d’un test prédictif de la chimiothérapie dans le cancer du sein (Oncotype DX®) en France (2012) (29)
Predictive and Prognostic Value of the TauProtein in Breast Cancer. (2015) (29)
Expression of sigma 1 receptor in human breast cancer (2004) (29)
Plastic surgery for breast conservation therapy: how to define the volume of the tumor bed for the boost? (2014) (29)
Development and Validation of a Nomogram for Predicting Outcome of Patients With Vulvar Cancer (2006) (28)
Four-year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes (2012) (28)
Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie (2018) (28)
Breast cancer in young women: Pathologic features and molecular phenotype. (2016) (28)
Pronostic et fertilité après traitement conservateur d’une tumeur ovarienne à la limite de la malignité : revue d’une série continue de 68 cas (2002) (28)
Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes. (2015) (27)
High rate of PIK3CA mutations but no TP53 mutations in low‐grade adenosquamous carcinoma of the breast (2018) (27)
Tattooing Breast Cancers Treated with Neoadjuvant Chemotherapy (2007) (27)
Malignant female adnexal tumor of probable wolffian origin relapsing after pregnancy. (2004) (27)
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome (2019) (27)
Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases. (2016) (26)
Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: an external validation study. (2012) (26)
Survival in cervix cancer patients treated with radiotherapy followed by radical surgery. (2005) (26)
Pregnancy after breast cancer: a need for global patient care, starting before adjuvant therapy. (2010) (26)
Laparoscopic versus laparotomic radical en bloc hysterectomy and colorectal resection for endometriosis (2010) (25)
Radiofrequency Thermal Ablation of Breast Cancer Local Recurrence: A Phase II Clinical Trial (2008) (25)
Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy (2015) (25)
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer (2020) (25)
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy (2015) (25)
Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma (2015) (25)
Surgical resection of liver metastases from breast cancer. (2010) (24)
Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responses (2008) (24)
Development and validation of nomograms for predicting preterm delivery. (2011) (24)
Spontaneous rectovaginal fistula during bevacizumab therapy for ovarian cancer: a case report. (2009) (23)
Surgery for Vulvar Cancer (2005) (23)
Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant setting. (2011) (23)
Superficially Invasive Carcinoma of the Vulva: Diagnosis and Treatment (2005) (23)
Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer (2013) (23)
The role of completion surgery after concurrent radiochemotherapy in locally advanced stages IB2-IIB cervical cancer. (2013) (23)
Pathologic Response Rate After Concomitant Neo-Adjuvant Radiotherapy and Chemotherapy for Adenocarcinoma of the Uterine Cervix: A Retrospective Multicentric Study (2010) (23)
Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor. (2006) (23)
Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer (2011) (22)
Update on the role of laparoscopy in the treatment of gynaecological malignancy (2005) (22)
Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes. (2016) (22)
Sentinel lymph node procedure followed by laparoscopic pelvic and paraaortic lymphadenectomy in women with IB2-II cervical cancer (2007) (22)
Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma (2014) (21)
Genital prolapse repair using porcine skin implant and bilateral sacrospinous fixation: midterm functional outcome and quality-of-life assessment. (2009) (21)
[Cost-effectiveness of a chemotherapy predictive test]. (2012) (21)
Antibacterial-Coated Suture in Reducing Surgical Site Infection in Breast Surgery: A Prospective Study (2012) (21)
Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas (2013) (21)
Épidémiologie des néoplasies vulvaires intraépithéliales (2007) (21)
Expression of somatostatin type-2 and -4 receptor and correlation with histological type in breast cancer. (2014) (21)
Secondary Complete Cytoreduction in Recurrent Ovarian Cancer: Benefit of Optimal Patient Selection Using Scoring System (2014) (21)
Non-Sentinel Lymph Node Metastasis Prediction in Breast Cancer with Metastatic Sentinel Lymph Node: Impact of Molecular Subtypes Classification (2012) (21)
Axillary lymph node micrometastases decrease triple-negative early breast cancer survival (2016) (20)
Contribution of Lymphoscintigraphy for Sentinel Lymph Node Biopsy in Women with Early Stage Endometrial Cancer: Results of the SENTI-ENDO Study (2014) (20)
Diagnostic Performance of Ultrasound-Guided Fine-Needle Aspiration of Nonpalpable Breast Lesions in a Multidisciplinary Setting: The Institut Curie’s Experience (2017) (20)
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers. (2019) (19)
Prise en charge des CIN1 (2008) (19)
HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports (2019) (19)
External validation of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing interval debulking surgery. (2011) (19)
Clues pointing to simple hysterectomy to treat early-stage cervical cancer. (2009) (18)
Experience with TachoSil in obstetric and gynecologic surgery (2011) (18)
[Laparoscopic pelvic exenteration for cervical cancer relapse: preliminary study]. (2006) (18)
A suggested modification to FIGO stage III vulvar cancer. (2008) (18)
Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer (2016) (18)
Lymph node positivity in different early breast carcinoma phenotypes: a predictive model (2019) (18)
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit (2019) (18)
The patient-breast cancer care pathway: how could it be optimized? (2015) (18)
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study. (2018) (18)
Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients. (2014) (18)
Individualized chemotherapy treatment for breast cancer: is it necessary? Is it feasible? (2004) (18)
Association of the number of sentinel lymph nodes harvested with survival in breast cancer. (2015) (18)
Effects of pelvic organ prolapse repair on urinary symptoms: A comparative study between the laparoscopic and vaginal approach (2012) (18)
Gene expression profiling of primary breast cancer (2005) (17)
Endométriose rectale et fertilité (2008) (17)
Wound complications after bevacizumab treatment in patients operated on for ovarian cancer. (2010) (17)
Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study (2021) (17)
Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancer. (2011) (17)
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial. (2018) (17)
Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors (2012) (17)
Development of a nomogram to predict occurrence of preeclampsia. (2008) (16)
Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell Carcinomas (2019) (16)
Evaluation of a method of predicting lymph node metastasis in endometrial cancer based on five pre-operative characteristics. (2014) (16)
Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer (2021) (16)
Determinants of geographic inequalities in HPV vaccination in the most populated region of France (2017) (16)
[Colorectal endometriosis and fertility]. (2008) (16)
Limits of Day-Before Lymphoscintigraphy to Localize Sentinel Nodes in Women with Cervical Cancer (2008) (16)
Unusual presentation of Bartholin's gland duct cysts: anterior expansions (2005) (16)
[Epidemiology and risk factors for cancer of the uterus]. (2014) (15)
Impact of Neoadjuvant Chemotherapy on the Rate of Bowel Resection in Advanced Epithelial Ovarian Cancer. (2016) (15)
Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France (2012) (15)
Non-Invasive Tools for the Diagnosis of Potentially Life-Threatening Gynaecological Emergencies: A Systematic Review (2015) (15)
[Assessment of the urinary side effects after surgery for deep pelvic endometriosis]. (2007) (15)
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers (2017) (15)
Comparison of Morbidity and Survival Between Primary and Interval Cytoreductive Surgery in Patients After Modified Posterior Pelvic Exenteration for Advanced Ovarian Cancer (2012) (15)
Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery (2016) (14)
Safety of sentinel node biopsy in pregnant patients. (2005) (14)
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact (2018) (14)
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study (2017) (14)
From prospective biobanking to precision medicine: BIO-RAIDs – an EU study protocol in cervical cancer (2015) (14)
Accuracy of diagnosis on CT scan of Surgicel® Fibrillar: results of a prospective blind reading study. (2013) (14)
[Prognostic and predictive factors in multifocal breast carcinoma]. (2011) (13)
[Complications of radical surgery for advanced ovarian cancer]. (2011) (13)
Quality of life after sentinel lymph node biopsy in early breast cancer. (2004) (13)
Surgical Procedures in Benign Vulval Disease (2009) (13)
Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators (2017) (13)
Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models (2015) (13)
Anorectal symptoms before and after laparoscopic sacrocolpoperineopexy for pelvic organ prolapse (2012) (13)
Discordance with local guidelines for adjuvant chemotherapy in breast cancer: reasons and effect on survival. (2011) (13)
Prospective study of the impact of using the 21-gene recurrence score assay on clinical decision making in women with estrogen receptor-positive, HER2-negative, early-stage breast cancer in France. (2012) (13)
Pregnancy stimulates tumor angiogenesis in breast carcinoma. (2014) (13)
HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer (2021) (12)
An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they? (2013) (12)
Complications de la chirurgie radicale des cancers de l’ovaire de stade avancé (2011) (12)
Survival Impact of Lymphadenectomy Stratified by Nodal Metastatic Probability in Endometrial Cancer (2014) (12)
Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma (2009) (12)
Intérêt des questionnaires de qualité de vie chez les patientes porteuses d’une endométriose (2009) (12)
Direct comparison of logistic regression and recursive partitioning to predict chemotherapy response of breast cancer based on clinical pathological variables (2009) (12)
[Management of CIN1]. (2008) (12)
Correlation of immunohistopathological expression of somatostatin receptor-2 in breast cancer and tumor detection with 68Ga-DOTATOC and 18F-FDG PET imaging in an animal model. (2013) (12)
Eutopic endometrium and peritoneal, ovarian and colorectal endometriotic tissues express a different profile of nectin-1, -3, -4 and nectin-like molecule 2. (2012) (12)
Interest in cavity shaving in breast conservative treatment does not depend on lumpectomy technique. (2011) (12)
Préservation de la fertilité, contraception et traitement hormonal de la ménopause chez les femmes traitées pour tumeurs malignes rares de l’ovaire : recommandations du réseau national dédié aux cancers gynécologiques rares (TMRG/GINECO) (2018) (12)
[Autologous breast reconstruction with latissimus dorsi flap]. (2000) (11)
Dépistage du cancer du sein : en route vers le futur (2016) (11)
Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer (2020) (11)
Intérêt du dosage du CA 125 dans la prise en charge du cancer de l’ovaire (2011) (11)
[Interest of CA 125 level in management of ovarian cancer]. (2011) (11)
Frozen section examination of the endocervical margin of cervical conization specimens. (2003) (11)
Outcome of oncoplastic breast-conserving surgery following bracketing wire localization for large breast cancer. (2015) (11)
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort (2015) (11)
Quels sont les meilleurs critères d’évaluation de la résécabilité dans les cancers de l’ovaire de stade avancé ? (2009) (10)
Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application (2016) (10)
Première enquête de satisfaction dans une unité de chirurgie ambulatoire dédiée à la cancérologie (2016) (10)
Benign lipoblastomalike tumor of the vulva: report of a case affecting a young patient. (2007) (10)
Has tumor doubling time in breast cancer changed over the past 80 years? A systematic review (2021) (10)
[Epidemiology of vulvar intra-epithelial neoplasias]. (2007) (10)
Urological morbidity of colorectal resection for endometriosis. (2012) (9)
Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆ (2021) (9)
Enabling Equal Access to Molecular Diagnostics: What Are the Implications for Policy and Health Technology Assessment? (2016) (9)
Prognostic Value of the 2009 FIGO Staging for Endometrial Cancer: An Illustration of the E3N Cohort (2012) (9)
Distinct p 53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers (2011) (9)
Prise en charge des tumeurs ovariennes à la limite de la malignité (2003) (9)
Les adénocarcinomes du col utérin ont-ils un plus mauvais pronostic que les carcinomes épidermoïdes ? (2004) (9)
Dynamic Analysis of CA125 Decline During Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer as a Predictor for Platinum Sensitivity. (2016) (9)
Development and validation of a nomogram to predict the risk of cesarean delivery in macrosomia (2008) (9)
Choroidal melanoma and pregnancy (2016) (8)
[Review of national and international guidelines for sentinel lymph node biopsy and complementary axillary dissection in breast cancer]. (2017) (8)
Cancer du sein dcouvert pendant la grossesse: particularits cliniques et diagnostiques (2009) (8)
Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study (2017) (8)
Risque de cancer du sein lié à la grossesse (2008) (8)
A nomogram to predict for malignant diagnosis of BI‐RADS category 4 breast lesions (2010) (8)
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach (2019) (8)
Computing Molecular Signatures as Optima of a Bi-Objective Function: Method and Application to Prediction in Oncogenomics (2015) (8)
Efficacité d’une stratégie d’application des recommandations vaccinales anticoqueluche en post-partum : un impact limité (2010) (8)
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program (2021) (8)
Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression. (2018) (8)
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis (2016) (8)
Vaccination HPV : principes, résultats et perspectives (2007) (8)
Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer. (2011) (8)
Sexual well-being in patients with vulvar disease: results from a preliminary prospective matched case-control study. (2015) (8)
[Advanced ovarian cancer: criteria of resectability]. (2009) (8)
Reexcision for positive margins in breast cancer: A predictive score of residual disease. (2015) (8)
Clinical validation of a model predicting the risk of preterm delivery (2017) (8)
Tumeurs borderline de l’ovaire : état des lieux (2008) (8)
[First outpatient satisfaction questionnaire with day-surgery in a French comprehensive cancer center]. (2016) (8)
[Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?]. (2004) (7)
Simultaneous early ovarian and endometrial cancer treated conservatively with spontaneous pregnancy (2013) (7)
Analyse économique des coûts de la chimiothérapie adjuvante du cancer du sein en France (2012) (7)
Modèles prédictifs d’envahissement des ganglions non sentinelles en cas de métastases des ganglions sentinelles dans le cancer du sein (2009) (7)
[Risk of breast cancer related to pregnancy]. (2008) (7)
[Prognostic factors and treatment for advanced-stage borderline ovarian tumors]. (2002) (7)
Impact de l’épidémie de COVID-19 sur les demandes de prise en charge initiale pour cancer du sein (2020) (7)
Facteurs prédictifs et pronostiques des cancers du sein multifocaux (2011) (7)
[Impact of the COVID-19 epidemic on requests for initial care for breast cancer]. (2020) (7)
A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant therapy in patients with FIGO stage IIIc/IV ovarian, tubal, or peritoneal adenocarcinoma, initially unresectable. (2014) (7)
A new method of DNA probes selection and its use with multi-objective neural network for predicting the outcome of breast cancer preoperative chemotherapy (2008) (7)
Traitement de l’hypertrophie des petites lèvres. Évaluation de la nymphoplastie de réduction par résection longitudinale (2012) (7)
Direct Comparison of Logistic Regression and Recursive Partitioning to Predict Lymph Node Metastasis in Endometrial Cancer (2015) (6)
[Somatostatin in breast cancer]. (2011) (6)
Retroperitoneal Lymphangioleiomyoma Mimicking Ovarian Tumor Emerging After Tamoxifen Therapy (2006) (6)
Postoperative complications in neoadjuvant treatment including bevacizumab for HER2-positive inflammatory breast cancer (IBC): Results from a phase II prospective trial. (2011) (6)
Résultats carcinologiques et fertilité après traitement conservateur des cancers épithéliaux invasifs de l’ovaire (2002) (6)
Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study (2019) (6)
Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database (2019) (6)
External Validation of a Laparoscopic-Based Score to Evaluate Resectability of Advanced Ovarian Cancers : Clues for a Simplified Score (2008) (6)
[Impact of nutrition on breast cancer mortality and risk of recurrence, a review of the evidence]. (2019) (6)
Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB). (2017) (6)
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer (2020) (5)
Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma (2022) (5)
23 Pregnancy-associated breast cancer is as chemosensitive as classic breast cancer in the neoadjuvant setting (2010) (5)
Age impact on human papillomavirus vaccination in France in 2014: A study from the National Health Insurance Database. (2015) (5)
A catalog of numerical centrosome defects in epithelial ovarian cancers (2022) (5)
Correction of uterine prolapse by the vaginal route using the uterosacral ligaments: Shirodkar procedure. (2003) (5)
A nomogram to predict subsequent brain metastasis in metastatic breast cancer (MBC) patients (2008) (5)
[Evaluation of labia minora reduction by longitudinal resection]. (2012) (5)
[Relevance of quality of life questionnaires in women with endometriosis]. (2009) (5)
Semi-supervised model applied to the prediction of the response to preoperative chemotherapy for breast cancer (2011) (5)
[Breast cancer screening: On our way to the future]. (2016) (5)
Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers (2017) (5)
Modalités et limites du traitement conservateur des adénocarcinomes in situ du col utérin : analyse de neuf cas et revue de la littérature (2003) (5)
Grossesse après cancer du sein : mise à jour des connaissances en 2012 (2012) (5)
[Regression of vaccine coverage HPV: A French exception]. (2017) (5)
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference (2012) (5)
Preoperative CT or PET/CT to Assess Pelvic and Para-Aortic Lymph Node Status in Epithelial Ovarian Cancer? A Systematic Review and Meta-Analysis (2021) (5)
Evaluation and Selection of Quality Indicators for the Management of Endometrial Cancer (2017) (5)
[Borderline ovarian tumors: an update]. (2008) (5)
Impact of immunohistochemical analysis of sentinel lymph node biopsy on breast cancer management. (2012) (5)
Prediction of axillary lymph node status in male breast carcinoma. (2013) (5)
Multidisciplinary management of advanced ovarian cancer for an optimal therapeutic strategy. (2017) (5)
Impact des régimes alimentaires sur la mortalité et le risque de récidive de cancer du sein : revue de la littérature (2020) (5)
[Prognosis and fertility after conservative treatment for ovarian tumors of limited malignity: review of 68 cases]. (2002) (5)
Prediction of axillary lymph node status in male breast carcinoma. (2013) (5)
[Conservative management of malignant and borderline ovarian tumor]. (2002) (4)
Place du traitement chirurgical locorégional chez les patientes présentant un cancer du sein métastatique d’emblée (2015) (4)
Exentérations pelviennes par laparoscopie: Technique opératoire et résultats d’une première série de cinq cas (2006) (4)
A case of isolated torsion of the fallopian tube: Added value of magnetic resonance imaging (2011) (4)
Centrosome amplification favours survival and impairs ovarian cancer progression (2019) (4)
Faisabilité du ganglion sentinelle dans le cancer invasif du sein en cas de découverte histologique de la multifocalité (2009) (4)
[Androgen receptors in breast cancer: Expression, value and therapeutic prospects]. (2017) (4)
Cancer du sein associé à la grossesse (2011) (4)
Cancer du col utérin opérable de stade précoce par chirurgie minimale invasive. Recommandations des chirurgiens du groupe GINECO (2019) (4)
[Life after uterine cancer]. (2014) (4)
LYMPH NODE INVOLVEMENT IN EPITHELIAL OVARIAN CANCER: ANALYSIS OF 276 PELVIC AND PARA-AORTIC LYMPHADENECTOMIES (2003) (4)
Non-parametric kernel density estimation for the prediction of neoadjuvant chemotherapy outcomes (2010) (4)
Le ganglion sentinelle dans les cancers gynécologiques (2002) (4)
[Locoregional surgery for stage IV breast cancer patients]. (2015) (4)
CCR 20th Anniversary Commentary: Divide and Conquer—Breast Cancer Subtypes and Response to Therapy (2015) (4)
The Google news effect: did the tainted milk scandal in China temporarily impact newborn feeding patterns in a maternity hospital? (2010) (4)
Adherence to Guidelines During Follow-up of Endometrial Cancer: Analysis of French Health Insurance Database. (2018) (4)
[Impact of sentinel node technique on the survival in patients with vulvar cancer: analysis of the Surveillance, Epidemiology, and End Results (SEER) database]. (2012) (4)
The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer: When might multigene assays be of value? (2017) (4)
[Pregnancy after breast cancer: an update]. (2012) (4)
Modalités de fonctionnement d’un centre de suivi des femmes à haut risque de cancer du sein et de l’ovaire : une expérience à l’hôpital Tenon (2010) (4)
Downsizing Multigenic Predictors of the Response to Preoperative Chemotherapy in Breast Cancer (2008) (4)
Prosigna test in breast cancer: real-life experience (2021) (4)
Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study (2021) (4)
[HPV vaccination: principles, results and future perspectives]. (2007) (4)
Pathological Characteristics of Both Tumors in Bifocal and Bicentric Breast Cancer. (2015) (4)
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]. (2018) (4)
Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer (2021) (4)
Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study (2016) (4)
CHIP et cancer de l’ovaire (2019) (3)
[Initial management of advanced ovarian cancer: What radiological, pathological and surgical information are important for optimal therapeutic strategy?]. (2015) (3)
[Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer]. (2017) (3)
Prospective multicenter study of the impact of the Prosigna assay on adjuvant clinical decision-making in women with early stage breast cancer: which patients are the best candidates? (2016) (3)
Impact sur la survie de la procédure du ganglion sentinelle dans le cancer de la vulve : analyse de la SEER database (2012) (3)
Colpohystérectomie élargie par laparoscopie. Technique et difficultés opératoires. Hystérectomie radicale (2005) (3)
Évaluation des troubles urinaires après chirurgie de l'endométriose profonde (2007) (3)
Prédicteurs clinicopathologiques et génomiques de la réponse à la chimiothérapie néoadjuvante dans les cancers du sein (2010) (3)
Transvaginal hydrolaparoscopy: practices in French teaching hospitals. (2008) (3)
Cancers et grossesse (2006) (3)
Prévenir : nouvelles recommandations vaccinales pour la prévention de la coqueluche (2007) (3)
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR (2018) (3)
Absenteeism and indirect costs during the year following the diagnosis of an operable breast cancer: a prospective multicentric cohort study. (2020) (3)
Estimation de l’évolution des connaissances sur les infections à Papillomavirus humain (HPV) : résultats d’une enquête téléphonique (2010) (3)
Couverture vaccinale contre la coqueluche chez les femmes accouchées (2008) (3)
Ganglion sentinelle et chimiothérapie néoadjuvante dans le cancer du sein (2017) (3)
Predictive factors for breast cancer in patients diagnosed with ductal intraepithelial neoplasia, grade 1B. (2012) (3)
[Efficacy of systematic information and prescription of vaccine to implement the recommendations to prevent post-partum pertussis: A limited impact]. (2010) (3)
[Breast cancer: nomograms to predict pathologic response after preoperative chemotherapy]. (2009) (3)
Validation de la version française du Female Sexual Function Index auprès d’un échantillon de la population féminine française (2013) (3)
Structuration nationale pour la prise en charge des cancers en cours de grossesse : réseau CALG (cancers associés à la grossesse) (2008) (2)
Anti‐cancer agents for breast cancer treatment during pregnancy (2011) (2)
Stage 1A squamous cell carcinoma of the vulva. (2006) (2)
Cancers du sein associés à la grossesse (2013) (2)
[How to surgery for advanced ovarian serous cancers?]. (2014) (2)
[Sentinel lymph nodes in gynecologic cancers]. (2002) (2)
Validation and comparison of nomograms and scores to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph node: a prospective multicentric study. (2009) (2)
2766 Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial (2015) (2)
[Models to predict non sentinel lymph node status in breast cancer patients with metastatic sentinel lymph node]. (2009) (2)
États pathologiques du sein pendant la grossesse (2009) (2)
Early PSA Decrease-based Nomogram to Predict Biochemical Failure in Patients with Localized Prostate Cancer Treated by Radiotherapy Only (2008) (2)
[Hot flushes and breast cancer with positive hormone receptors: Mechanisms and management]. (2020) (2)
Comparative analysis of durable responders on immune checkpoint inhibitors (ICI) versus other systemic therapies: A meta-analysis of phase III trials. (2018) (2)
Missed opportunities and challenges for surgical breast cancer research in the era of personalized cancer treatment. (2019) (2)
Épidémiologie, prévention et dépistage du cancer du col de l'utérus (2015) (2)
Bayesian Classifiers for Predicting the Outcome of Breast Cancer Preoperative Chemotherapy (2008) (2)
[Feasibility of the sentinel node biopsy in breast cancer in case of histological multifocality diagnosis]. (2009) (2)
[Results and fertility after conservative treatment of invasive epithelial ovarian cancer]. (2002) (2)
Threatened preterm birth: Validation of a nomogram to predict the individual risk of very preterm delivery in a secondary care center. (2019) (2)
Individual benefits from adjuvant anthracycline-based chemotherapy can be predicted from a predictive nomogram created from primary chemotherapy (PC) data: Results of a randomized trial (2005) (2)
Genomic profile of breast cancer (2015) (2)
[Physical activity after breast cancer diagnosis and survival: A systematic review]. (2020) (2)
Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (2020) (2)
Variation over time of the factors influencing return to work and work capacities after a diagnosis of breast cancer: a study on the behalf of the Seintinelles research network (2022) (2)
The patient-breast cancer care pathway: how could it be optimized? (2015) (2)
O150 External validation of a laparoscopic‐based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score (2009) (2)
[How i do: install extraperitoneal para-aortic single-port lymphadenectomy]. (2012) (2)
P1-10-06: Economic Analysis of Chemotherapy Costs for Adjuvant Therapy in Breast Cancer in France. (2011) (2)
Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France (2022) (2)
Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy (2005) (2)
EP967 Natural history of patients with BRCA-mutated high grade epithelial ovarian cancer (HGEOC) before the era of PARP inhibitors maintenance in 1st line treatment (2019) (2)
Comment informer une patiente qui désire une grossesse après cancer du sein (2007) (2)
New Multi-Objective Algorithms for Neural Network Training Applied to Genomic Classification Data (2009) (2)
La grossesse et l’AMP sont-elles raisonnables après un cancer du sein ? (2008) (2)
PMD51 Cost-Effectiveness of a Predictive Test of the Benefit of Chemotherapy (2012) (2)
A specific nomogram to predict subsequent brain metastasis in metastatic triple-negative breast cancer patients. (2009) (2)
Préservation de la fertilité chez les patientes atteintes d’un cancer du col de plus de 2 cm (2016) (2)
Les décisions des RCP sont-elles conformes au référentiel utilisé ? Expérience d’un centre de référence universitaire pour le cancer du sein (2013) (2)
Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study) (2021) (2)
Comment je fais pour installer une lymphadénectomie para-aortique rétropéritonéale par mono-trocart ? (2012) (2)
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database. (2021) (2)
Colpoplasty by laparoscopic modified Davydov's procedure. (2017) (2)
14PADOPTION OF MULTI-GENE ASSAYS IN HR +, HER2– BREAST CANCER (BC) PATIENTS IN EUROPE: RESULTS OF THE MULTIDISCIPLINARY APPLICATION OF GENOMICS IN CLINICAL PRACTICE (MAGIC) SURVEY (2014) (2)
Value of Diaphragmatic Surgery During Interval Debulking Surgery. (2018) (2)
Les récepteurs aux androgènes dans le cancer du sein : expression, valeur et perspectives thérapeutiques (2017) (2)
Désir de grossesse et cancer du sein (2019) (2)
Caractérisation moléculaire des cancers du sein en pratique clinique (2016) (2)
Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study. (2021) (2)
Can the centrosome be a marker for DNA ploidy in breast cancer? (2012) (2)
Denaturing fixatives are compatible with the NanoString nCounter® platform and the Prosigna® assay. (2017) (1)
Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer. (2021) (1)
[Modalities and limits of conservative treatment of adenocarcinoma in situ of the uterine cervix: analysis of nine cases and review of the literature]. (2003) (1)
[Molecular characterization of breast cancer in clinical practice]. (2016) (1)
Correlation of baseline clinical characteristics and laparoscopic extent of carcinomatosis of women with initially unresectable ovarian, tubal or peritoneal adenocarcinoma, in ANTHALYA study: A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant (2015) (1)
CCR 20 th Anniversary Commentary : Divide and Conquer — Breast Cancer Subtypes and Response to Therapy (2015) (1)
Molecular profiles as a function of treatment response/progression free survival in a prospective cervical cancer study (RAIDs). (2018) (1)
[Fertility sparing treatment in women affected by cervical cancer larger than 2cm]. (2016) (1)
INGUINO-FEMORAL DISSECTION FOR CARCINOMA OF THE VULVA: EFFECT OF MODIFICATIONS OF EXTENT AND TECHNIQUE ON MORBIDITY AND SURVIVAL (2003) (1)
Douleurs du sein (2007) (1)
Laparoscopic perineal hernia repair following pelvic exenteration: a case report (2021) (1)
Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy (2016) (1)
Traitement cœlioscopique de l’endométriose pelvienne profonde : résultats sur la qualité de vie (2007) (1)
2022-RA-205-ESGO Circulating HPV DNA in cervical cancer: a marker for early detection of relapse (2022) (1)
Le nerve-sparing dans la chirurgie de l'endométriose (2009) (1)
[Anxiety and depressive disorders in patients during the Covid-19 pandemic]. (2020) (1)
Rôle du médecin généraliste dans le suivi du cancer du sein (2007) (1)
Abstract P3-07-63: Ki67 cut-off point to predict the benefit of adjuvant chemotherapy in ER+ HER2- breast cancer patients (2016) (1)
Complete resection rate at interval debulking surgery after bevacizumab containing neoadjuvant therapy: primary objective of the ANTHALYA trial (2016) (1)
[Minimal invasive surgery for early stage cervical cancer. Recommendations from the GINECO surgeon's group]. (2019) (1)
Associated Lichen Sclerosis Increases the Risk of Lymph Node Metastases of Vulvar Cancer (2020) (1)
[Feasibility and tolerance of Sienna+® for the procedure of sentinel lymph node biopsy: Single centre pilot study of 30 consecutive patients]. (2017) (1)
A phase 3 randomized double-blind trial of maintenance with niraparib versus placebo in patients with platinum-sensitive ovarian cancer ( ENGOT-OV 16 / NOVA trial ) (2014) (1)
[Episode-based bundled payment model: evaluation of medical costs for early operable breast cancer]. (2021) (1)
Optimisation du nomogramme de réponse à la chimiothérapie néo-adjuvante du MDACC pour un schéma utilisant plus de 4 cycles d’anthracycline (2012) (1)
Abstract P4-14-12: Evaluation of the effect of pasireotide LAR administration in the lymphocele prevention after mastectomy with axillary lymph node dissection for breast cancer: results of a phase 2 randomized study. (2012) (1)
Apport du PMSI dans l’évaluation du cancer de l’ovaire avancé (2018) (1)
Correlation of ultrasound, cytological, and histological features of 110 benign BI‐RADS categories 4C and 5 nonpalpable breast lesions. The Institut Curie's experience (2021) (1)
Vers quelle chirurgie pour les cancers séreux avancés de l’ovaire ? (2014) (1)
La prévention du cancer du col de l'utérus (2007) (1)
Laparoscopic pelvic lymph node dissection. (2011) (1)
Troubles anxieux et depressifs des patientes pendant la pandémie Covid-19 (2020) (1)
[Pertussis vaccine coverage in postpartum women]. (2008) (1)
Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group (2021) (1)
Impact de la tarification 2014 sur le développement de la chirurgie du sein en ambulatoire (2015) (1)
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort. (2022) (1)
[Clues for paraaortic lymphadenectomy in patients older than 70 years with ovarian cancer]. (2012) (1)
Validation externe de 2 scores prédictifs de récidive de tumeurs mucineuses et séreuses borderline de l’ovaire : le nomogramme de Bendifallah et le score d’Ouldamer (2017) (1)
Management of Vulval Cancers (2009) (1)
Chimiothérapie des récidives des cancers de l’ovaire (2012) (1)
Breast conservation in the treatment of T2 breast tumors – analysis of 1988-2003 SEER data. (2009) (1)
Skin Lesions after Prophylactic Mastectomy and Immediate Reconstruction (2013) (1)
Structuration nationale pour la prise en charge des cancers en cours de grossesse: réseau CALG (2013) (1)
Faisabilité et tolérance de Sienna+ ® pour la détection du ganglion sentinelle : étude pilote unicentrique sur 30 cas consécutifs (2017) (1)
Étude mono-institutionnelle de 117 cas de cancers du sein associés à la grossesse (CSAG) : données cliniques, radiologiques, histo-pathologiques et évolutives (2014) (1)
Erratum à l'article : « Dépistage du cancer du sein : en route vers le futur ¼ [Bull. Cancer 103 (2016) 753763]. (2016) (1)
Detection and diagnosis (2012) (1)
Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study (2018) (1)
Adjuvant chemotherapy in elderly breast cancer patients: Pattern of use and impact on overall survival (2019) (1)
Syndrome du choc toxique staphylococcique après chirurgie du sein (2014) (1)
Vulve et vagin (2010) (1)
Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort (2018) (1)
A Pre-operative Score to Discriminate Fibroepithelial Lesions of the Breast: Phyllode Tumor or Fibroadenoma? (2020) (1)
Interest of the intraoperative POCI camera for breast cancer SLN biopsy: Clinical conclusive results (2008) (1)
[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]]. (2016) (1)
Faut-il vacciner nos filles contre le cancer du col utérin ? (2007) (1)
[How shall we inform a patient who wants a pregnancy after a breast cancer?]. (2007) (1)
Prognostic role of serum Ca 15-3 and circumstances of diagnostic in advanced breast cancer: Data from a prospective randomized trial. (2004) (1)
Chirurgie conservatrice des tumeurs malignes et borderline de l'ovaire (2003) (1)
235P Breast cancer and perceived discrimination in the workplace: A longitudinal cohort study (2020) (1)
Bouffées de chaleur et cancer du sein avec récepteurs hormonaux positifs : mécanismes et prise en charge (2020) (1)
Le Comité d’éthique de la recherche en obstétrique et gynécologie (CEROG) (2010) (1)
Are maternal characteristics different in women with preeclampsia from those with gestational hypertension at first prenatal visit (2005) (1)
947PCirculating tumor cells as prognostic marker in ovarian carcinoma: Results from the ANTHALYA study (2017) (1)
Épidémiologie et facteurs de risque des cancers de l'utérus (2014) (1)
[Desire for pregnancy and breast cancer]. (2019) (1)
The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases (2022) (1)
Masses ovariennes : démarche diagnostique et prise en charge des tumeurs bénignes et malignes (2007) (1)
[Cancer and pregnancy]. (2012) (1)
Abstract P1-01-14: Effects of axillary lymph node dissection on survival of patients with sentinel lymph node metastasis of breast cancer in the Surveillance, Epidemiology and End Results (SEER) database using a propensity score matching analysis (2012) (1)
Erector spinae plane block versus thoracic paravertebral block for the prevention of acute postsurgical pain in breast cancer surgery: A prospective observational study compared with a propensity score-matched historical cohort (2022) (1)
Clinical Subtype-Derived p53 Gene Signature Is Predictive of Prognosis and Response to Chemotherapy in ER-Positive but Not in ER-Negative Breast Cancers. (2009) (1)
Performances prédictives du TEP-TDM et du nomogramme CGFL/Curie après chimiothérapie néoadjuvante du cancer du sein (2020) (0)
[Sentinel lymph node biopsy in invasive breast cancer in 2009]. (2009) (0)
REPRODUCTIVE IMAGING: I-59: DIAGNOSTIC ACCURACY OF PHYSICAL EXAMINATION, TRANSVAGINAL SONOGRAPHY, RECTAL ENDOSCOPIC SONOGRAPHY, AND MAGNETIC RESONANCE IMAGING TO DIAGNOSE DEEP INFILTRATING ENDOMETRIOSIS (2010) (0)
Impact of Vulvar Cancer Surgery on Quality of Sex Life: A Review of Literature. (2021) (0)
Abstract P6-06-07: 5-year disease free-survival results of aggressively-treated breast cancer during pregnancy: Results from a French multicenter study (2013) (0)
A new design of clinical trial – use of nomograms – illustration with local treatment of T2 tumors in the SEER database. (2009) (0)
Lymph node positivity in different early breast carcinoma phenotypes: a predictive model (2019) (0)
Abstract P1-03-05: A comprehensive molecular analysis of medullary breast carcinoma: A model of immunomodulatory triple negative breast cancer subtype (2017) (0)
P2-12-06: Nomogram To Predict Subsequent Bone Metastasis in Patients with Non Metastatic Breast Carcinomas. (2011) (0)
Direct medical and non-medical costs of a one-year care pathway for early breast cancer: results of a French multicenter prospective study (2019) (0)
Current Perspectives for External Control Arms in Oncology Clinical Trials: Analysis of EMA approvals 2016-2021. (2023) (0)
368 Anthracyclin-based neoadjuvant chemotherapy for large breast carcinoma: predictors and significance of breast preserving surgery (2003) (0)
HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports (2019) (0)
Impact of β-catenin phosphorylation patterns on tumour control/progression in a prospective cervical cancer study (RAIDs) (2019) (0)
Immunohistochemical profiles of normal and tumor breast from BRCA1 carriers and matched sporadic controls: Clues for chemoprevention. (2004) (0)
Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism. (2023) (0)
Author and Subject Index (2002) (0)
Response to the letter "More data along with further definitions are required" by Sahin et al. (2016) (0)
Predictive Biomarkers and Personalized Medicine Distinct p 53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers (2011) (0)
Abstract P3-06-11: Withdrawn (2018) (0)
Surgical management of peritoneal carcinomatosis in ovarian cancer (2014) (0)
The benefit of combined maternal administration of magnesium sulfate and aminophylline. (2006) (0)
18F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab (2021) (0)
[The lymph node in breast cancer: feasibility study and initial experience. E. Barranger et al. Gynécol Obstét Fertil 2002;30:492-7]. (2002) (0)
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis (2022) (0)
[Prediction performances of 18F-FDG PET and CGFL/Curie nomogram after preoperative chemotherapy in Breast cancer]. (2020) (0)
[Institutional review board of the French college of obstetricians and gynecologists (CEROG).]. (2010) (0)
High-risk endometrial carcinoma: MRI findings (2014) (0)
746P Real-world clinical outcomes of patients with de novo advanced high-grade epithelial ovarian cancer eligible to niraparib maintenance in France (2021) (0)
69TiP A pilot study of combined biomarker-based treatment strategies in patients with recurrent/metastatic squamous cell carcinoma of the cervix: RAIDS molecular targets trial for cervical cancer (2020) (0)
[Use of social networks in oncology]. (2022) (0)
[Are decisions of multidisciplinary tumor boards in accordance with the guidelines? Experience of an university reference center for breast cancer]. (2013) (0)
Benefit of adjuvant chemotherapy and/or trastuzumab in T1ab node-negative human epidermal growth factor receptor 2–positive breast carcinomas: Results of a national multi-institutional study. (2016) (0)
[Update on precursors of vulvar carcinoma]. (2020) (0)
[Are centrosomal abnormalities correlated to DNA ploidy in breast cancer?]. (2011) (0)
Development and Validation of Nomograms for Predicting Preterm Delivery (2012) (0)
OT2-07-01: Pasireotide Long Acting Release (LAR) in Breast Cancer Patients To Prevent Lymphocele after Mastectomy and Axillary Node Dissection: A Randomized, Multicenter, Phase II Study. (2011) (0)
Abstract P6-16-02: Fertility preservation in young breast cancer patients: Real life data on 1390 patients treated in the Institut Curie (2019) (0)
62PDPrognosis of multifocal/multicentric breast cancers (2015) (0)
925PMATCHED COHORT STUDY ON PATIENTS WITH CERVICAL CANCER DIAGNOSED DURING PREGNANCY. (2014) (0)
Abstract P2-06-23: A New Way To Determine Multifocality: The Use of Molecular Markers? (2010) (0)
Superiority of 2 doses of HPV-16/18 As04-adjuvanted vaccine versus 2 or 3 doses of HPV-6/11/16/18 vaccine: a randomised immunogenicity trial (2015) (0)
Abstract P2-03-04: Lymphovascular invasion in breast carcinoma following neodjuvant chemotherapy is a strong prognosis factor (2018) (0)
IS NODAL METASTASIS IN OVARIAN CANCER ARE CHEMOSENSITIVE LESIONS¿ ANALYSIS OF NODAL INVOLVEMENT IN 105 PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY (2003) (0)
[Carbon footprint and cancer: Time for green oncology?] (2020) (0)
098 Limitations in clinical practice guideline implementation in cancer care: feedback from routine use of a computerized decision support system (OncoDoc2) in breast cancer management (2010) (0)
O810 Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer (2009) (0)
295PTRADITIONAL PROGNOSTIC FACTORS USED FOR ADJUVANT CHEMOTHERAPY (CT) DECISIONS IN EARLY STAGE HR + , HER2- BREAST CANCER IN A LARGE INTERNATIONAL SURVEY (MAGIC) AMONG BREAST CANCER SPECIALISTS. (2014) (0)
Abstract P2-01-11: Prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: The MSKCC nomogram and the Tenon score – PHRC-NOTEGS study (2015) (0)
[Staphylococcal toxic shock syndrome after breast surgery]. (2014) (0)
157. Comparing medical oncologists' and surgeons' treatment recommendations in early stage HR+, HER2– breast cancer (BC) patients (pts): A subanalysis of the Multidisciplinary Application of Genomics in Clinical Practice (MAGIC) survey (2014) (0)
869P Prognostic impact of HPV ctDNA detection during chemoradiotherapy for cervix carcinoma (2020) (0)
[Effectiveness of "threshold" in the management of ovarian cancer: A review of the literature]. (2016) (0)
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area (2020) (0)
[Prophylaxis and management of cancer-associated thrombosis: Practical issues about anticoagulant use]. (2022) (0)
Eligibility for ACOSOG Z0011 Trial and Results on a Cohort of 3546 Breast Cancer Patients with Micro or Macro Metastases Sentinel Nodes (2020) (0)
261PDTHE EFFECT OF PHYSICIAN'S CHARACTERISTICS ON ADJUVANT CHEMOTHERAPY (CT) DECISIONS FOR EARLY STAGE HR + , HER2- BREAST CANCER (BC) PATIENTS (PTS). (2014) (0)
Impact of hormone receptor status in HER2+ early breast cancer: A paradigm shift in the trastuzumab era. (2018) (0)
HER2-positive breast cancer: Combined 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab. (2019) (0)
A multidisciplinary approach to oncology trials: Study conduct of the ANTHALYA trial. (2018) (0)
PIN94 HUMAN PAPILLOMAVIRUS (HPV) VACCINE COVERAGE RATES (VCR) IN FRANCE: A FRENCH CLAIMS DATA STUDY (2019) (0)
06 - SURGICAL STAGING PRIOR TO CHEMORADIATION IS BENEFICIAL FOR SURVIVAL IN PATIENTS WITH HIGH STAGE CERVICAL CANCER (2019) (0)
Immunohistochemical profiles of normal and tumor breast from BRCA1 carriers and matched sporadic controls: Clues for chemoprevention (2004) (0)
Abstract P6-08-06: The multidisciplinary application of genomics in clinical practice (MAGIC) survey: Identification of early stage hormone receptor-positive (HR+), HER2– breast cancer (BC) patients for whom multigene assays may be valuable (2015) (0)
Low centrosome numbers correlate with higher aggressivity in ovarian cancer (2022) (0)
Parenthood, maternal mental health, early interactions and child development in the context of a maternal cancer diagnosed during pregnancy or the post-partum (2012) (0)
[Breast cancer. In favour of models to predict non-sentinel lymph node status]. (2010) (0)
Perceived discrimination at work: examining social, health and work-related factors as determinants among breast cancer survivors – evidence from the prospective CANTO cohort (2022) (0)
[External multicentric validation of two scores predicting the risk of relapse in patients with borderline ovarian tumors: The nomogram of Bendifallah and the score of Ouldamer]. (2017) (0)
Elderly patients with early breast cancer (BC) are less likely to receive adjuvant chemotherapy (AdjCT) irrespective of disease risk factors: The multidisciplinary application of genomics in clinical practice (MAGIC) survey (2014) (0)
Abstract 4330: HPV double capture NGS method in cervical cancer: Identification of MACROD2 gene as HPV hot spot integration site and viral load status as a prognostic factor (2020) (0)
428 The predictive value of specimen radiography to predict margins involvement in 188 breast infraclinic carcinomas (2003) (0)
Physician-to-physician communication in breast cancer care coordination. (2017) (0)
PIN103 Trends in Human Papillomavirus (HPV) Vaccine Coverage Rates (VCR) in France: A French Claims DATA Study (2020) (0)
[Clinicopathological and genomics predictors of response to neoadjuvant chemotherapy in breast cancer]. (2010) (0)
Real-World Data on Newly Diagnosed BRCA-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database (2022) (0)
Immunological superiority of 2-dose As04-hpv-16/18 vaccine schedule versus 2-dose and 3-dose schedules of 4vhpv at month36: a randomized, multicentre trial (2016) (0)
[Prevention: new whooping cough vaccination guidelines]. (2007) (0)
Abstract P2-08-21: Outcomes results of Prosigna® test in early breast cancer patients: Experience of Institut Curie, France (2020) (0)
Impact of bowel resection on overall survival after neoadjuvant chemotherapy in advanced epithelial ovarian cancer. (2015) (0)
70PEstimating benefit of adjuvant chemotherapy for breast cancer patients on the individual level (2015) (0)
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site (2023) (0)
THREE TYPES OF LAPAROSCOPIC EXENTERATION FOR CERVICAL CANCER RELAPSE (2004) (0)
P105 The MAGIC survey in HR+, HER2− breast cancer (BC): when might multigene assays be of value? (2015) (0)
[Quality control of the surgical management of advanced ovarian carcinoma]. (2012) (0)
Abstract OT2-04-01: Optisoins01: Optimizing the patient-breast cancer care pathway; An observational multicentric prospective study (2016) (0)
P1088 A suggested modification to FIGO stage III vulvar cancer (2009) (0)
Sexuality after breast cancer, how to provide a global and contemporary approach. (2022) (0)
Vaccination HPV et grossesse : Mise en place d'un registre national (2007) (0)
European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer. (2017) (0)
Abstract PS1-43: Axillary surgery after neoadjuvant chemotherapy in patients treated for an operable breast cancer with a proven initially positive axillary node: Preliminary results of identification and removal of the initially positive axillary node (2021) (0)
Development of a nomogram to predict preeclampsia (2005) (0)
Dynamic analysis of CA-125 decline during neoadjuvant chemotherapy in patients with epithelial ovarian cancer as a predictor for sensitivity to platinum. (2014) (0)
Benefit of adjuvant systemic therapies in HR+ HER2- pT1ab node-negative breast carcinomas. (2018) (0)
Abstract P5-21-14: Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: Real-life results from the Curie ESME database (2018) (0)
Iconography : Laparoscopic pelvic lymph node dissection (2011) (0)
[Impact of the COVID-19 pandemic on breast cancer management: Experience of a French Comprehensive Cancer Center]. (2022) (0)
Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes (2023) (0)
Abstract OT2-03-02: DI study: Decision impact of the NanoString® Technologies Prosigna™ in early breast cancers (2016) (0)
Abstract P1-14-21: Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: Development of a specific predictor (2016) (0)
[Therapeutic de-escalation in breast cancer surgery]. (2021) (0)
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer (2020) (0)
P3-14-11: Comparison of Two Nomograms To Predict Pathologic Complete Response to Neoadjuvant Chemotherapy – Evidence That HER2 Positive Tumors Need Specific Predictors. (2011) (0)
Anorectal symptoms before and after surgical repair of pelvic organ prolapse. (2011) (0)
Abstract A43: Centrosome amplification favors survival and impairs ovarian cancer progression (2020) (0)
Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast. (2018) (0)
Abstract P6-14-06: Oral etoposide (VP-16) in heavily pre-treated metastatic breast cancer: A multicenter national observational study (2018) (0)
Abstract P5-07-05: Development of individual adjuvant chemotherapy benefit estimating program for breast cancer patients management (2016) (0)
A mathematical model to predict for pre-malignant or malignant diagnosis among patients with Birad 4 breast lesions. (2006) (0)
[Modalities for the functionning of a Care Center for women at high risk for breast and ovarian cancers: The French experience of Tenon Hospital]. (2010) (0)
897PNEOADJUVANT THERAPY IN ADVANCED OVARIAN CANCER PATIENTS: EFFICIENCY OF SCREENING BY LAPAROSCOPY FOR CLINICAL TRIAL RECRUITMENT. (2014) (0)
Primary C hemotherapy f or O perable B reast C ancer: Incidence a nd P rognostic S ignificance o f I psilateral B reast Tumor R ecurrence A fter B reast-Conservin g S urgery (2001) (0)
Borrelial lymphocytoma of the breast: a rare differential diagnosis of breast cancer. (2022) (0)
Commentaire invité, de l’article de Leconte et al. sur le traitement chirurgical de l’endométriose rectale (2007) (0)
177 Associated lichen sclerosis increases the risk of lymph node metastases of vulvar cancer (2015) (0)
Surgical management of Low-Grade Serous Carcinoma of the ovary: Results of a multicenter study from The French National Network dedicated to Ovarian Malignant Rare Tumors (TMRO) (2019) (0)
Polarity gene alterations in pure invasive micropapillary carcinomas of the breast (2014) (0)
Abstract P2-05-04: Evaluation of intra-tumor heterogeneity, test reproducibility and their impact in breast cancer samples assessed by Prosigna™: Results from a decision impact prospective study and a matched case-control study (2017) (0)
From prospective biobanking to precision medicine: BIO-RAIDs – an EU study protocol in cervical cancer (2015) (0)
Geometry of the fusiform excision for skin lesions (2020) (0)
[Indications and achievements of the extension assessment in breast cancer in France]. (2019) (0)
[Should we vaccinate our daughters against cervical cancer?]. (2007) (0)
Laparoscopic lumbo-aortic lymph node dissection. (2011) (0)
[Mammary duct papilloma: How I do… a microdochectomy wire guided]. (2017) (0)
Management of borderline ovarian tumors in women younger than 45 years (2018) (0)
Human Papillomavirus (HPV)-16/18 AS04-adjuvanted Vaccine: Immunological Superiority of the 2-dose Schedule Versus 2-dose and 3-dose schedules of HPV-6/11/16/18 Vaccine; Results of a Randomised, Multicentre, Immunogenicity Trial Up to Month 24 (2015) (0)
[The sentinel lymph node in cancer of the breast: clinical aspects]. (2003) (0)
Rate of pathological complete response in early HER2 breast cancer. (2022) (0)
[Evolution of the awareness of Human Papillomavirus (HPV) in the French population: Results of a telephonic inquiry]. (2010) (0)
Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective study. (2022) (0)
Abstract P1-01-19: Prediction of axillary lymph node status in male breast carcinoma (2012) (0)
Reply: To PMID 22546083. (2013) (0)
Predictive and prognostic nomograms for breast cancer treated with primary chemotherapy (PC) (2005) (0)
Abstract P1-03-10: A Model To Prevent Pregnancy Associated Breast Cancer: The Effect of HCG on Tumorigenesis in MMTVneu Mice (2010) (0)
Performances of a hand-held gamma camera for breast cancer sentinel node biopsy: Final results of a prospective double blinded study (2011) (0)
Patient attributes considered for decision-making with regard to adjuvant chemotherapy in early stage HR+, HER2-breast cancer patients : Results of the Multidisciplinary Application of Genomics in Clinical Practice (MAGIC) survey (2014) (0)
2022-RA-703-ESGO Primary and interval debulking surgery in advanced ovarian cancer: real-world clinical outcomes of patients in 1st line setting, analysis from the french national ESME-unicancer database (2022) (0)
Interest of an intraoperative imaging probe for sentinel lymph node biopsy in breast cancer: First clinical results (2007) (0)
Abstract P2-08-08: Isolated ipsilateral local recurrence of breast cancer: Predictive factors and prognostic impact (2019) (0)
[Bisphenol A and breast cancer: State of knowledge and meta-analysis]. (2022) (0)
Is surgery possible after pelvic irradiation (2011) (0)
Prediction of chemosensitivity of breast tumors treated with primary chemotherapy using clinical nomograms (2007) (0)
Erratum: Expression of sigma 1 receptor in human breast cancer (Breast Cancer Research and Treatment (2004) 87 (205-214)) (2005) (0)
ODALIE Study, a retrospective analysis of a real-life cohort of patients with de novo advanced high grade epithelial ovarian cancer treated with a first-line platinum- and taxane-based chemotherapy combined with bevacizumab. (2022) (0)
Absenteeism and indirect costs during the year following the diagnosis of an operable breast cancer (2019) (0)
Empreinte carbone et cancer : l’heure de la green oncology ? (2020) (0)
379 Real world retrospective study of patients with epithelial ovarian cancer: an international comparison (2020) (0)
Abstract P2-14-10: Prosigna® test in clinical routine: Impact on adjuvant chemotherapy decision and medico-economic considerations in France (2020) (0)
Abstract P1-07-02: 5-year overall survival of early breast cancer during pregnancy: A multicenter French case control study (2016) (0)
158. Comparing medical oncologists and surgeons in adoption of multigene assays for early stage HR+, HER2– breast cancer patients: A subanalysis of the Multidisciplinary Application of Genomics in Clinical Practice (MAGIC) survey (2014) (0)
175P Prosigna test for early breast cancer patients in real-life (2021) (0)
59 Indications of adjuvant chemotherapy for breast cancer according to local guidelines, recursive partition and Adjuvant! Online: how to improve patient management? (2010) (0)
[Erratum to « Update on precursors of vulvar carcinoma» [Gynecol. Obstet. Fertil. Senol. 49 (2021]]. (2021) (0)
EP1217 Surgical staging prior to chemoradiation is beneficial for survival in patients with high stage cervical cancer (2019) (0)
205 PI3K-epigenetic ‘metagene’ alterations were associated with PFS but appear independent of FIGO-2018 stage in cervival patients enrolled in the prospective european bioraids study (2019) (0)
Abstract P2-11-21: Ipsilateral breast tumor recurrence in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: Validation of the MD Anderson prognostic index (2013) (0)
[Genomic tests in early breast cancer management: Real-life experience]. (2017) (0)
Abstract P2-16-14: HER2-positive breast cancer: Combined18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab (2020) (0)
[Who should operate on patients with breast cancer?]. (2008) (0)
"Individualized assessment of preterm birth risk using two modified prediction models" from M. Mailath-Pokorny and colleagues. (2015) (0)
Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study (2017) (0)
Abstract P2-19-01: Impact of bone-only metastatic breast cancer on outcome in a real-life setting: A comprehensive analysis of 5,041 women from the ESME database (2020) (0)
The Remoyal of Regional Nodes EYen When "Pathologically NegatiYe" for Long-term Survival Should be Discussed Cautiously (2004) (0)
Tumeurs du vagin intraépithéliales et invasives (2013) (0)
Indications et réalisations du bilan d’extension dans le cancer du sein en France (2019) (0)
Les tumeurs multifocales, multicentriques (2013) (0)
Prise en charge des cancers de l’ovaire de stade avancé : debulking initial ou chirurgie d’intervalle ? (2012) (0)
Iconography : Exentérations pelviennes par laparoscopie (2008) (0)
Intérêt des examens systématiques de suivi après traitement radiochirurgical des cancers du col utérin aux stades I/II (2003) (0)
Iconographies supplémentaires de l'article : États pathologiques du sein pendant la grossesse (2017) (0)
Bisphénol A et cancer du sein : état des lieux des connaissances et méta-analyse (2022) (0)
Autoévaluations de l'article : Épidémiologie, prévention et dépistage du cancer du col de l'utérus (2015) (0)
Les coûts environnementaux liés aux transports dans l’évaluation économique d’un parcours de soins : application à la prise en charge du cancer du sein dans l’ouest francilien (2022) (0)
Les nomogrammes: vers une médecine individualisée (2010) (0)
Chapitre 14 – Prise en charge et traitement du cancer de la vulve et du vagin (2013) (0)
Le concept du ganglion sentinelle : une révolution dans la prise en charge de l’envahissement ganglionnaire – revue avec focus sur le cancer du sein (2022) (0)
Tests génomiques en situation adjuvante du cancer du sein : expérience en vie réelle (2017) (0)
Les néoplasies vulvaires intra-épithéliales (2008) (0)
SURVEILLANCE DES PATIENTES TRAITÉES POUR CANCER DU SEIN (2008) (0)
Résultats du traitement conservateur chez les patientes ayant une tumeur épithéliale maligne de l'ovaire (2003) (0)
Prévention et prise en charge des thromboses associées au cancer: questions pratiques à propos de l’anticoagulation (2022) (0)
Iconographies supplémentaires de l'article : Épidémiologie, prévention et dépistage du cancer du col de l'utérus (2015) (0)
Arbres décisionnels de l'article : États pathologiques du sein pendant la grossesse (2017) (0)
Cancer du sein. Pour les modèles prédictifs d’atteinte des ganglions non sentinelles (2010) (0)
Cancer du sein en cours de grossesse (2010) (0)
Cancer du sein associé à la grossesse : traitement (2010) (0)
Cancer du col de l'utérus (2007) (0)
Femmes à haut risque de cancer mammaire : vers des unités et réseaux de surveillance (2011) (0)
Étude préliminaire de l'évaluation de la qualité de vie comme critère décisionnel pour la chirurgie du prolapsus génital Pilot study of assessment of quality of life as a criterion to be used when deciding on surgery for genital prolapse (2011) (0)
Le ganglion dans le cancer du sein : étude de faisabilité et expérience initiale (2002) (0)
42. Chirurgie ambulatoire et cancer du sein : identification des facteurs de réussite à l’Institut Curie (2013) (0)
Autoévaluations de l'article : États pathologiques du sein pendant la grossesse (2017) (0)
Erratum à « Lésions vulvaires précancéreuses » [Gynecol. Obstet. Fertil. Senol. 49 (2021)] (2021) (0)
Critères de choix d'une chimiothérapie néoadjuvante (2013) (0)
Développement d’un prédicteur clinicopathologique du risque de métastases osseuses dans le cancer du sein (2013) (0)
Le traitement chirurgical des carcinomes épidermoïdes de la vulve : Techniques chirurgicales en gynécologie pelvienne (2005) (0)
Validation externe du KELIM standardisé et du score de récidive résistante au platine chez les patientes atteintes d'un cancer épithélial de l'ovaire avancé (2022) (0)
Épidémiologie des infections et maladies génitales à HPV chez les femmes sans suivi gynécologique (2011) (0)
Arbres décisionnels de l'article : Épidémiologie, prévention et dépistage du cancer du col de l'utérus (2015) (0)
Service de Gynécologie-Obstétrique, hôpital Tenon, AP-HP, CancerEst, (2009) (0)
Application d’un modèle prédictif de malignité en cas d’hyperplasie canalaire atypique diagnostiquée par une macrobiopsie : étude de validation (2012) (0)
Predicteurs clinicopathologiques et genomiques de la reponse ala chimiotherapie neoadjuvante dans les cancers du sein Clinicopathological and genomics predictors of response to neoadjuvant chemotherapy in (2010) (0)
Génétique des cancers de l’ovaire et prise en charge des personnes à haut risque (2012) (0)
Iconography : Cancer du col de l'utérus (2007) (0)
Prise en charge initiale du cancer de l’ovaire avancé : quelles sont les informations radiologiques, anatomo-pathologiques et chirurgicales importantes pour une stratégie thérapeutique optimale ? (2015) (0)
Impact de la pandémie de COVID-19 sur la prise en charge du cancer du sein : retour d’expérience d’un centre de lutte contre le cancer (2022) (0)
Malformations du vagin (2005) (0)
Évaluation du rapport coût-efficacité de l’apport de l’Oncotype DX® pour la prise en charge du cancer du sein en France (2012) (0)
Arbres décisionnels de l'article : Cancers et grossesse (2016) (0)
Iconographies supplémentaires de l'article : Cancers et grossesse (2016) (0)
Facteurs de décision en chirurgie (2012) (0)
Grossesse, contraception, fertilité et cancer (2013) (0)
Quand le féminin est mis à mal … À propos d’une prise de poids significative chez des jeunes femmes en post-annonce diagnostique d’une agénésie utéro-vaginale (2020) (0)
Contrôle qualité de la prise en charge chirurgicale des cancers de l’ovaire de stades avancés (2012) (0)
Scores de prédictivité de la réponse à la chimiothérapie néoadjuvante (2008) (0)
Augmentation de l’angiogenèse mais non de la lymphangiogenèse dans le cancer du sein associé à la grossesse comparé au cancer du sein hors grossesse (2012) (0)
Le curage pelvien par cœlioscopie (2011) (0)
Étude préliminaire de l’évaluation de la qualité de vie comme critère décisionnel pour la chirurgie du prolapsus génital (2011) (0)
Quelle chirurgie après chimiothérapie néoadjuvante (2013) (0)
Comparaison de 2 nomogrammes prédisant la réponse complète à la chimiothérapie néo-adjuvante, preuve que les HER2+ nécessitent un prédicteur spécifique (2012) (0)
Autoévaluations de l'article : Rôle du médecin généraliste dans le suivi du cancer du sein (2007) (0)
Prévention des infections du site opératoire : étude prospective de l’intérêt de l’utilisation du fil coate au Triclosan® en chirurgie mammaire (2012) (0)
Iconographies supplémentaires de l'article : Exentérations pelviennes par laparoscopie (2008) (0)
Utilisation des réseaux sociaux en oncologie (2022) (0)
Le curage lomboaortique par cœlioscopie (2011) (0)
@@112053@@ : Rôle du médecin généraliste dans le suivi du cancer du sein (2007) (0)
Apport du profil d'expression génique pour déterminer la chimiosensibilité des cancers du sein (2005) (0)
Corrélation entre les anomalies centrosomiques et l’ADN-ploïdie dans le cancer du sein (2011) (0)
Étude prospective de l’impact de l’utilisation du test de 21 gènes, le Recurrence Score, sur les décisions thérapeutiques prises chez les femmes ayant un cancer du sein à un stade précoce HER2 négatif et avec des récepteurs aux œstrogènes positifs (2013) (0)
Iconography : Rôle du médecin généraliste dans le suivi du cancer du sein (2007) (0)
Iconography : Vaccination HPV : principes, résultats et perspectives (2008) (0)
24. Évaluation de l’effet du pasiréotide dans la diminution des lymphocèles après mastectomie et curage axillaire pour un cancer du sein (2013) (0)
Efficacité des « seuils » dans la prise en charge des cancers de l’ovaire : revue de la littérature (2016) (0)
Les métastases ganglionnaires des cancers de l'ovaire sont-elles chimio-sensibles ? Analyse de l'atteinte ganglionnaire chez 105 patientes traitées par chimiothérapie préopératoire: Are nodal metastasis in ovarian cancer chemosensitive lesions? Analysis of nodal involvement in 105 patients treated w (2003) (0)
Analyse mathématique prédictive de l’efficacité de la chimiothérapie néoadjuvante chez les patientes ayant un cancer du sein (2006) (0)
Comparaison des performances prédictives du TEP-TDM et du nomogramme CGFL/Curie pour prédire la réponse histologique complète après chimiothérapie néo-adjuvante des cancers du sein HER2-positifs (2020) (0)
Autoévaluations de l'article : Cancers et grossesse (2016) (0)
@@112053@@ : Cancer du col de l'utérus (2007) (0)
Chapitre 8 – Imagerie des cancers génitaux féminins (2013) (0)
Points communs et différences entre les divers nomogrammes validés pour le calcul du risque d’envahissement ganglionnaire (2012) (0)
Qui doit opérer les cancers du sein (2008) (0)
Activité physique après diagnostic de cancer du sein et survie : revue de la littérature (2020) (0)
Chapitre 21 – Cancer et grossesse (2014) (0)
Signature d’expression génique dans le cancer du sein en adjuvant : le RIHN, une modalité d’accès aux innovations (2015) (0)
Iconographies supplémentaires de l'article : Cancer du col de l'utérus (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roman Rouzier?

Roman Rouzier is affiliated with the following schools: